For those of you who are interested Health Canada is inviting stakeholders to comment on the revised guidance documents on Post-Notice of Compliance (NOC) changes for Quality. The draft […]
Paving the Way for Application of Next Generation Risk Assessment to Safety Decision-making for Cosmetic Ingredients was recently published in the Regulatory Toxicology and Pharmacology Volume 125 in Science […]
The Natural and Non-prescription Health Products Directorate (NNHPD) recently launched Phase 1 of the implementation of the Self-Care Framework with the “pre-publication” in Canada Gazette Part 1 of a proposal to […]
With the pandemic the Natural and Non-prescription Health Products Directorate was focused on expediting applications to meat the demands of the pandemic. Starting on October 1, 2021, NNHPD will […]
Health Canada has created a new Drug Establishment Licensing (DEL) Bulletin webpage. As of August 10, 2021, all new DEL Bulletins will be posted to the webpage. DEL bulletins […]
On August 10, 2021, the Health Product Compliance Directorate posted the GUI-0050 – Annex 11 to the GMP Guide. This guide is an annex to the Good manufacturing practices […]
Health Canada amended the Food and Drug Regulations on March 18, 2021, to transition authorizations and drug establishment licences (DEL) issued under the Interim Order Respecting the Importation, Sale […]
Further to our “Urgent Development Notice” issued late last week concerning a new information request issued by the Consumer and Hazardous Products Safety Directorate (CHPSD) regarding polyfluoroalkyl substances (PFAS), […]
Cosmetics Alliance just became aware of an Information request from the Consumer & Hazardous Safety Directorate (CHPSD) regarding polyfluoroalkyl substances (PFAS) in cosmetics based on the study Fluorinated Compounds […]
Environment and Climate Change Canada (ECCC) released on July 21, 2021 the Order to amend the Domestic Substances List (DSL) applying the Significant New Activity (SNAc) provisions of CEPA to […]
